GB1440603A - Alkyl phosphonates - Google Patents

Alkyl phosphonates

Info

Publication number
GB1440603A
GB1440603A GB2306775A GB2306775A GB1440603A GB 1440603 A GB1440603 A GB 1440603A GB 2306775 A GB2306775 A GB 2306775A GB 2306775 A GB2306775 A GB 2306775A GB 1440603 A GB1440603 A GB 1440603A
Authority
GB
United Kingdom
Prior art keywords
alkyl
alkyl phosphonates
formula
phosphonates
pfizer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2306775A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/355,644 external-priority patent/US4094899A/en
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of GB1440603A publication Critical patent/GB1440603A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

1440603 Alkyl phosphonates PFIZER Inc 30 May 1973 [2 June 1972 30 April 1973] 23067/75 Divided out of 1440601 Heading C2P Novel alkyl phosphonates of the formula CH 3 (CH2) m O(CH 2 ) n (CH 2 ) 2 C(O)CH 2 P(O)O(CH 3 ) 2 wherein m is 0, 1, 2, 3 or 4 and n is 0, 1 or 2, are prepared by reacting dimethyl methylphosphonate with alkyl esters of the formula wherein R is C 1-5 alkyl.
GB2306775A 1972-06-02 1973-05-30 Alkyl phosphonates Expired GB1440603A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25921572A 1972-06-02 1972-06-02
US05/355,644 US4094899A (en) 1972-06-02 1973-04-30 Oxaprostaglandins

Publications (1)

Publication Number Publication Date
GB1440603A true GB1440603A (en) 1976-06-23

Family

ID=26947161

Family Applications (3)

Application Number Title Priority Date Filing Date
GB2306575A Expired GB1440602A (en) 1972-06-02 1973-05-30 Cyclopentane derivatives
GB2306775A Expired GB1440603A (en) 1972-06-02 1973-05-30 Alkyl phosphonates
GB2584673A Expired GB1440601A (en) 1972-06-02 1973-05-30 Oxaprostaglandins

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB2306575A Expired GB1440602A (en) 1972-06-02 1973-05-30 Cyclopentane derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB2584673A Expired GB1440601A (en) 1972-06-02 1973-05-30 Oxaprostaglandins

Country Status (19)

Country Link
JP (3) JPS5314062B2 (en)
AR (2) AR199300A1 (en)
CA (1) CA1095034A (en)
CH (3) CH590224A5 (en)
DD (2) DD124594A5 (en)
DE (2) DE2327813A1 (en)
DK (1) DK143498C (en)
ES (2) ES441002A1 (en)
FI (1) FI55995C (en)
GB (3) GB1440602A (en)
IE (1) IE38568B1 (en)
IL (2) IL42373A (en)
IN (1) IN138739B (en)
LU (1) LU67738A1 (en)
NL (1) NL162902C (en)
NO (1) NO145438C (en)
PH (3) PH11300A (en)
SE (4) SE415756B (en)
YU (1) YU36497B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES416865A1 (en) * 1972-07-13 1976-03-01 Pfizer 15-substituted-omega-pentanorprostaglandins
US11756356B2 (en) 2019-08-28 2023-09-12 Igloocompany Pte. Ltd. System and method for controlling multiple locks

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3538120A (en) * 1967-05-22 1970-11-03 Ciba Geigy Corp Cyclopentyl-alkanoic acids
ZA721159B (en) * 1971-03-22 1972-12-27 Ici Ltd Process for the separation of the c-15 epimers of 20-ethyl-9a,11alpha,15-trihydroxy-5-cis-13-trans-prostadienoic acid

Also Published As

Publication number Publication date
YU146973A (en) 1982-02-25
SE7608222L (en) 1976-07-19
DE2344838B2 (en) 1981-04-09
IL50311A (en) 1977-08-31
NL162902C (en) 1980-07-15
SE418857B (en) 1981-06-29
GB1440601A (en) 1976-06-23
DD124594A5 (en) 1977-03-02
DD109859A5 (en) 1974-11-20
DK143498B (en) 1981-08-31
IE38568L (en) 1973-12-02
SE7608221L (en) 1976-07-19
CH589074A5 (en) 1977-06-30
FI55995B (en) 1979-07-31
FI55995C (en) 1979-11-12
IL42373A0 (en) 1973-07-30
NO740849L (en) 1973-12-04
JPS5231054A (en) 1977-03-09
JPS4954349A (en) 1974-05-27
CH586716A5 (en) 1977-04-15
DE2344839B2 (en) 1976-06-24
JPS5728706B2 (en) 1982-06-18
DE2344838A1 (en) 1973-12-20
ES441003A1 (en) 1977-03-16
NO145438B (en) 1981-12-14
LU67738A1 (en) 1973-12-10
IE38568B1 (en) 1978-04-12
PH11931A (en) 1978-09-13
GB1440602A (en) 1976-06-23
PH12035A (en) 1978-10-16
DE2344838C3 (en) 1982-03-18
PH11300A (en) 1977-11-02
NL162902B (en) 1980-02-15
DE2344839A1 (en) 1974-02-28
IN138739B (en) 1976-03-27
AU5639373A (en) 1974-12-05
CH590224A5 (en) 1977-07-29
NL7307740A (en) 1973-12-04
NO145438C (en) 1982-03-24
IL42373A (en) 1977-08-31
JPS5314062B2 (en) 1978-05-15
AR199300A1 (en) 1974-08-23
SE415756B (en) 1980-10-27
YU36497B (en) 1984-02-29
ES441002A1 (en) 1977-03-01
DE2327813A1 (en) 1973-12-20
DK143498C (en) 1982-01-11
SE7608223L (en) 1976-07-19
CA1095034A (en) 1981-02-03
AR203386A1 (en) 1975-09-08
JPS5239629A (en) 1977-03-28

Similar Documents

Publication Publication Date Title
ES422001A1 (en) Imidazo {8 5,1-f{9 -as-triazines
GB1307281A (en) Rubber-polyester compositions
SE7700718L (en) INTERMEDIATE PRODUCTS AND PROCEDURES FOR THE MANUFACTURE OF IT
IE38920L (en) Flameproofing polyesters
ES409436A1 (en) Isoindoline derivatives
ES418924A1 (en) 9,11,15-Trihydroxy prost-5-enoic acid analogues
ES416495A1 (en) N-tetrazolyl quinaldamides
GB1368080A (en) Polynuclear n-heterocyclic n,n -polyglycidyl compounds processes for their production and the use thereof
ES418114A1 (en) 5-Methylthio-pyrimidine vasodilators
GB1373549A (en) 3-halogenopyridazines and their preparation
ES428005A1 (en) 3,4-Dihydro-2H-naphthalene-1-one-5-oxypropyl-piperazine compounds
GB1440603A (en) Alkyl phosphonates
GB1437815A (en)
GB1388180A (en) Acetals
ES432939A1 (en) Disubstituted azabicycloalkanes
ES411563A1 (en) Coumarinimides
ES446666A1 (en) 5-phenyl-2-furamidoximes
GB1438129A (en)
ES417971A1 (en) Dibenzazecines
ES423950A1 (en) 6-Substituted 3-carbethoxyhydrazinopyridazine
GB1344839A (en) Sulphoniobutadiene salts and their production
GB1236947A (en) Process for the preparation of piperazine derivatives
GB1509454A (en) 2-amino-tetralins
ES422996A1 (en) Halogen-containing phosphoric acid esters
ES425628A1 (en) 1,2,3,4,10,14B-Hexahydro-pyridino{8 1,2-a{9 -dibenzo{8 c,f{9 -azepine

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee